Olic Akrapovic I, Radic M, Tonkic A. Is there higher percentage of undetected osteopenia and osteoporosis among patients with ulcerative colitis in Saudi Arabia? World J Gastroenterol 2021; 27(27): 4481-4483 [PMID: 34366618 DOI: 10.3748/wjg.v27.i27.4481]
Corresponding Author of This Article
Mislav Radic, PhD, Assistant Professor, Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, Soltanska 1, Split 21000, Croatia. mislavradic@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 21, 2021; 27(27): 4481-4483 Published online Jul 21, 2021. doi: 10.3748/wjg.v27.i27.4481
Is there higher percentage of undetected osteopenia and osteoporosis among patients with ulcerative colitis in Saudi Arabia?
Ivna Olic Akrapovic, Mislav Radic, Ante Tonkic
Ivna Olic Akrapovic, Intensive Care Unit of the Department of Internal Medicine, University Hospital Centre Split, Split 21000, Croatia
Mislav Radic, Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, Split 21000, Croatia
Mislav Radic, Ante Tonkic, School of Medicine, University of Split, Split 21000, Croatia
Ante Tonkic, Department of Gastroenterology and Hepatology, University Hospital Centre Split, Split 21000, Croatia
Author contributions: Akrapovic Olic I and Radic M designed research; Akrapovic Olic I performed research; Akrapovic Olic I and Radic M analyzed data; Akrapovic Olic I wrote the letter; Radic M and Tonkic A revised the letter.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mislav Radic, PhD, Assistant Professor, Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, Soltanska 1, Split 21000, Croatia. mislavradic@gmail.com
Received: January 17, 2021 Peer-review started: January 17, 2021 First decision: February 23, 2021 Revised: March 29, 2021 Accepted: June 25, 2021 Article in press: June 25, 2021 Published online: July 21, 2021 Processing time: 182 Days and 19.8 Hours
Abstract
Detection of prevalence and development of osteopenia or osteoporosis in patients with inflammatory bowel disease using only bone mineral density could be inappropriate to detect all individuals at risk for osteoporosis. Numerous patients could remain undetected by using only bone mineral density as a screening method, especially in patients with ulcerative colitis. Therefore, trabecular bone score should be used as a complementary method.
Core Tip: Lower body mass index is a predictor of osteoporosis in patients with inflammatory bowel disease however, fracture risk can be increased desite normal bone mineral density. Therefore, use of trabecular bone score would ensure recruitment of individuals with normal bone mineral density at increased risk of fractures in trials.
